{
    "nctId": "NCT01994369",
    "briefTitle": "Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)",
    "officialTitle": "A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Surgery Presenting Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Resectable Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "The ability of EC17 and the imaging system to detect FRA positive tumors during surgery conducted 2-4 hours post EC-17 administration.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Adult patients 18 years of age and older\n2. Patients presenting with breast cancer presumed to be resectable by lumpectomy and/or mastectomy on pre-operative assessment\n3. Good operative candidate\n4. Subject capable of giving informed consent and participating in the process of consent.\n\nExclusion Criteria:\n\n1. Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery\n2. Patients with a history of anaphylactic reactions to Folate-FITC or insects\n3. At-risk patient populations\n\n   1. \"People who would be easily lost to follow up (ex: People who are homeless or alcohol dependent)\n   2. Patients unable to participate in the consent process (children and neonates).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}